Literature DB >> 17983363

Reducing the risk of ventilator-acquired pneumonia through head of bed elevation.

Libby Keeley1.   

Abstract

BACKGROUND: It has been suggested that placing critically ill ventilated patients in a semirecumbent position minimizes the likelihood of nosocomial pneumonia. AIM: This pilot study explores whether the incidence of ventilator-acquired pneumonia (VAP) can be reduced by elevating the head of the bed to 45 degrees.
METHODS: The design is quantitative in nature, using a randomized controlled trial. The method involves adult ventilated patients being randomly assigned to one of two positions, i.e. 45 degrees raised head of bed (treatment group) or 25 degrees raised head of bed (control group). Data collection relied upon the diagnosis of clinically suspected and microbiologically confirmed pneumonia defined by the Consensus Conference on VAP.
RESULTS: Thirty patients were included in the study--17 in the treatment group and 13 in the control group. Results showed that 29% (five) in the treatment group and 54% (seven) in the control group contracted VAP (P < 0.176).
CONCLUSIONS: There was a trend towards a reduction in VAP in the patients nursed at 45 degrees. However, because of the sample size this difference did not reach statistical significance.

Entities:  

Mesh:

Year:  2007        PMID: 17983363     DOI: 10.1111/j.1478-5153.2007.00247.x

Source DB:  PubMed          Journal:  Nurs Crit Care        ISSN: 1362-1017            Impact factor:   2.325


  13 in total

1.  Preventing ventilator-associated pneumonia: is it ultimately only a matter of gravity?

Authors:  Ioannis Pneumatikos
Journal:  Intensive Care Med       Date:  2012-02-18       Impact factor: 17.440

2.  [Short version S2e guidelines: "Positioning therapy and early mobilization for prophylaxis or therapy of pulmonary function disorders"].

Authors:  T Bein; M Bischoff; U Brückner; K Gebhardt; D Henzler; C Hermes; K Lewandowski; M Max; M Nothacker; T Staudinger; M Tryba; S Weber-Carstens; H Wrigge
Journal:  Anaesthesist       Date:  2015-08       Impact factor: 1.041

3.  Prone position acute respiratory distress syndrome patients: less prone to ventilator associated pneumonia?

Authors:  H Dupont; P Depuydt; F Abroug
Journal:  Intensive Care Med       Date:  2016-01-14       Impact factor: 17.440

4.  A pilot study of pepsin in tracheal and oral secretions.

Authors:  Marilyn Schallom; Sally M Tricomi; Yie-Hwa Chang; Norma A Metheny
Journal:  Am J Crit Care       Date:  2013-09       Impact factor: 2.228

Review 5.  Backrest position in prevention of pressure ulcers and ventilator-associated pneumonia: conflicting recommendations.

Authors:  Ruth Srednicki Burk; Mary Jo Grap
Journal:  Heart Lung       Date:  2012-07-21       Impact factor: 2.210

6.  Ventilator-associated pneumonia prevention: one good turn does not always deserve another.

Authors:  Pedro Póvoa; Thiago Lisboa; José-Artur Paiva
Journal:  Intensive Care Med       Date:  2017-09-22       Impact factor: 17.440

Review 7.  Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation.

Authors:  Li Wang; Xiao Li; Zongxia Yang; Xueli Tang; Qiang Yuan; Lijing Deng; Xin Sun
Journal:  Cochrane Database Syst Rev       Date:  2016-01-08

Review 8.  An evidence-based recommendation on bed head elevation for mechanically ventilated patients.

Authors:  Barbara S Niël-Weise; Petra Gastmeier; Axel Kola; Ralf P Vonberg; Jan C Wille; Peterhans J van den Broek
Journal:  Crit Care       Date:  2011-04-11       Impact factor: 9.097

Review 9.  How to avoid microaspiration? A key element for the prevention of ventilator-associated pneumonia in intubated ICU patients.

Authors:  Stijn I Blot; Jan Poelaert; Marin Kollef
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

10.  Tissue hemoglobin index: a non-invasive optical measure of total tissue hemoglobin.

Authors:  Dean Myers; Michelle McGraw; Mark George; Kristine Mulier; Greg Beilman
Journal:  Crit Care       Date:  2009-11-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.